Shopping Cart
- Remove All
- Your shopping cart is currently empty
Anti-inflammatory agent 89 (5c) exhibits significant effects in alleviating pulmonary inflammation and restoring lung structure through its corticosteroid and H2S releasing components, making it a promising candidate for asthma research. It inhibits all characteristics of asthma.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | Backorder | |
50 mg | Inquiry | Backorder |
Description | Anti-inflammatory agent 89 (5c) exhibits significant effects in alleviating pulmonary inflammation and restoring lung structure through its corticosteroid and H2S releasing components, making it a promising candidate for asthma research. It inhibits all characteristics of asthma. |
In vitro | Anti-inflammatory agent 89 (100 μM, 24 h) did not reduce the viability of RBL-2H3 cells. |
In vivo | Anti-inflammatory agent 89 (1-2 mg/kg, administered 30 minutes prior to sensitization on days 0 and 7, continuous for 21 days) suppresses asthmatic traits by targeting pulmonary inflammation in mice sensitized with Ovalbumin (OVA). |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.